Deepak Mundhra
Senior Director Drug Product Manufacturing at Athira Pharma- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Credentials
-
Inclusive Leadership
LinkedInJul, 2021- Oct, 2024
Experience
-
Athira Pharma
-
United States
-
Biotechnology
-
1 - 100 Employee
-
Senior Director Drug Product Manufacturing
-
Jul 2022 - Present
Manage drug product development at Athira Pharma. Responsible for development, scale-up and tech transfer of Fosgonimeton subcutaneous injection for Alzheimer’s disease exclusively with CDMO partners. Early stage oral formulation for ATH-1105 for the treatment of ALS. Manage drug product development at Athira Pharma. Responsible for development, scale-up and tech transfer of Fosgonimeton subcutaneous injection for Alzheimer’s disease exclusively with CDMO partners. Early stage oral formulation for ATH-1105 for the treatment of ALS.
-
-
-
GSK
-
United Kingdom
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Scientific Leader, Pharmaceutical Development
-
Apr 2017 - Apr 2022
Product development (from GLP to commercial formulation) and process development, technical transfer, CMC modules submission authoring for Cabotegravir injectable suspension.
-
-
Investigator, Formulation Development
-
Jun 2006 - Apr 2017
-
-
-
Ranbaxy
-
India
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
scientist
-
2005 - 2006
-
-
Education
-
Saint John's University
Master's, Industrial Pharmacy -
University of Mumbai
B.Pharm, Pharmacy